Approval · Notice of Compliance 15897 · 2014
TAMIFLU: Notice of Compliance 15897
Issued July 31, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15897
- Date
- July 31, 2014
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Removal of tamiflu 123 mg/ml powder for oral solution strength
- Therapeutic class
- Antiviral agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TAMIFLU | Not yet assigned | — |
Medicinal ingredients
- OSELTAMIVIR PHOSPHATE 30 MG per CAP
- OSELTAMIVIR PHOSPHATE 45 MG per CAP
- OSELTAMIVIR PHOSPHATE 75 MG per CAP
- OSELTAMIVIR PHOSPHATE 6 MG per CAP